@lysfasano - **Tirzepatide: A dual GIP+GLP-1 receptor agonist**; it suppresses appetite and improves insulin sensitivity through two distinct pathways, offering superior efficacy in both weight loss and blood glucose control.
- **Semaglutide (Ozempic / Wegovy): A GLP-1 receptor agonist**